Legal Representation
Attorney
Randolph E. Digges, III
USPTO Deadlines
Next Deadline
740 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220215)
Due Date
February 15, 2028
Grace Period Ends
August 15, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
29 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 15, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 11, 2022 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jan 10, 2022 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Dec 20, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Nov 23, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Dec 17, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 23, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Oct 5, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 10, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 10, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 21, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 1, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 1, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 1, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 1, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 1, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 1, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jul 1, 2021 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jul 1, 2021 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Jun 8, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 8, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 7, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 11, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 15, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 15, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 15, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 8, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 30, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 25, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemical, biochemical and biotechnological diagnostic preparations for scientific purposes, namely, buffer solutions for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification and cloning; chemical test kits for laboratory or research use featuring chemicals for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid amplification and cloning
First Use Anywhere:
Aug 31, 2021
First Use in Commerce:
Aug 31, 2021
Class 005
Diagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic kits comprised of preparations for medical and veterinary diagnostic purposes, namely, preparations for marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes
First Use Anywhere:
Aug 31, 2021
First Use in Commerce:
Aug 31, 2021
Additional Information
Pseudo Mark
STABLE SCRIPT
Classification
International Classes
001
005